SEC Form 4 · accession 0001127602-18-032307
AMGEN INC · AMGN
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Murdo Gordon
Officer — EVP Global Commercial Ops
Period of report
Nov 2, 2018
Accepted (ET)
Nov 6, 2018 · 6:11 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000318154
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Nov 2, 2018 | A | 34,213 | $0.00 | A | 34,213 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1The Restricted Stock Units were granted pursuant to the Amgen Inc. 2009 Amended and Restated Equity Incentive Plan and vest in three installments of 35%, 35% and 30% on 11/2/2019, 11/2/2020 and 11/2/2021, respectively.